Provided by Tiger Trade Technology Pte. Ltd.

Spruce Biosciences, Inc.

61.48
-1.9200-3.03%
Post-market: 61.480.00000.00%19:30 EDT
Volume:91.77K
Turnover:5.68M
Market Cap:176.69M
PE:-1.60
High:64.50
Open:64.50
Low:60.46
Close:63.40
52wk High:240.00
52wk Low:7.26
Shares:2.87M
Float Shares:2.29M
Volume Ratio:1.00
T/O Rate:4.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-38.4300
EPS(LYR):-50.8298
ROE:-105.98%
ROA:-40.03%
PB:2.11
PE(LYR):-1.21

Loading ...

Spruce Biosciences initiated with a Buy at JonesResearch

TIPRANKS
·
Jun 09

Spruce says long-term TA-ERT data presented at MPS Symposium

TIPRANKS
·
Jun 09

Spruce Biosciences reports six-year tralesinidase alfa data showing sustained biomarker reductions, stabilized cognition in MPS IIIB

Reuters
·
Jun 09

Spruce Biosciences Announces Long-Term Tralesinidase Alfa Enzyme Replacement Therapy Data in Sanfilippo Syndrome Type B (Mps Iiib) Presented at the 18TH International Mps Symposium

THOMSON REUTERS
·
Jun 09

Spruce Biosciences Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jun 01

Spruce Biosciences, Inc : H.c. Wainwright Cuts Target Price to $150 From $200

THOMSON REUTERS
·
Jun 01

Spruce Biosciences Announces Data Presentation At The 18Th International MPS Symposium

Reuters
·
May 29

Spruce Biosciences to present long-term tralesinidase alfa data in Sanfilippo syndrome Type B at International MPS Symposium

Reuters
·
May 29

Spruce Biosciences Announces Data Presentation at the 18TH International Mps Symposium

THOMSON REUTERS
·
May 29

Spruce Biosciences to present at Jefferies Global Healthcare Conference

Reuters
·
May 28

Analysts’ Top Healthcare Picks: Spruce Biosciences (SPRB), CG Oncology, Inc. (CGON)

TIPRANKS
·
May 27

Spruce Biosciences Stockholders Approve Directors and Annual Say-on-Pay

TIPRANKS
·
May 27

Spruce Biosciences shareholders elect Class III directors at annual meeting

Reuters
·
May 27

Spruce Biosciences, Inc : Leerink Partners Cuts Target Price to $120 From $140

THOMSON REUTERS
·
May 14

Spruce Biosciences Is Maintained at Market Outperform by Citizens

Dow Jones
·
May 14

Spruce Biosciences price target lowered to $150 from $170 at Citizens

TIPRANKS
·
May 14

Spruce Biosciences reports Q1 EPS ($8.94), consensus ($6.11)

TIPRANKS
·
May 14

Spruce Biosciences, Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

Spruce Biosciences Q1 FY26 net loss narrows to $12.27 million; R&D expenses fall to $7.58 million

Reuters
·
May 13

Spruce Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates

THOMSON REUTERS
·
May 13